DZ2654A1 - Utilisations des kétolides pour la préparation de compositions pharmaceutiques destinées à prévenir les complications thrombotiques artérielles liées à l'arthérosclérose. - Google Patents

Utilisations des kétolides pour la préparation de compositions pharmaceutiques destinées à prévenir les complications thrombotiques artérielles liées à l'arthérosclérose.

Info

Publication number
DZ2654A1
DZ2654A1 DZ980264A DZ980264A DZ2654A1 DZ 2654 A1 DZ2654 A1 DZ 2654A1 DZ 980264 A DZ980264 A DZ 980264A DZ 980264 A DZ980264 A DZ 980264A DZ 2654 A1 DZ2654 A1 DZ 2654A1
Authority
DZ
Algeria
Prior art keywords
ketolides
atherosclerosis
preparation
pharmaceutical compositions
compositions intended
Prior art date
Application number
DZ980264A
Other languages
English (en)
French (fr)
Inventor
Francis Petit
Francoise Vacheron
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of DZ2654A1 publication Critical patent/DZ2654A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DZ980264A 1997-11-17 1998-11-16 Utilisations des kétolides pour la préparation de compositions pharmaceutiques destinées à prévenir les complications thrombotiques artérielles liées à l'arthérosclérose. DZ2654A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9714358A FR2771008B1 (fr) 1997-11-17 1997-11-17 Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose

Publications (1)

Publication Number Publication Date
DZ2654A1 true DZ2654A1 (fr) 2003-03-22

Family

ID=9513423

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980264A DZ2654A1 (fr) 1997-11-17 1998-11-16 Utilisations des kétolides pour la préparation de compositions pharmaceutiques destinées à prévenir les complications thrombotiques artérielles liées à l'arthérosclérose.

Country Status (35)

Country Link
US (1) US20080139489A1 (xx)
EP (1) EP1030673B1 (xx)
JP (1) JP4550273B2 (xx)
KR (1) KR20010032130A (xx)
CN (1) CN1286633A (xx)
AP (1) AP1196A (xx)
AR (1) AR014119A1 (xx)
AT (1) ATE271875T1 (xx)
AU (1) AU744419B2 (xx)
BG (1) BG104427A (xx)
BR (1) BR9814199A (xx)
CA (1) CA2312021C (xx)
DE (1) DE69825308T2 (xx)
DZ (1) DZ2654A1 (xx)
EA (1) EA003322B1 (xx)
EE (1) EE04095B1 (xx)
ES (1) ES2224446T3 (xx)
FR (1) FR2771008B1 (xx)
GE (1) GEP20032968B (xx)
HR (1) HRP20000314A2 (xx)
HU (1) HUP0004507A3 (xx)
ID (1) ID24940A (xx)
IL (1) IL136149A0 (xx)
MA (1) MA26566A1 (xx)
NO (1) NO20002435L (xx)
NZ (1) NZ504305A (xx)
OA (1) OA11411A (xx)
PL (1) PL340373A1 (xx)
SK (1) SK7042000A3 (xx)
TN (1) TNSN98206A1 (xx)
TR (1) TR200001384T2 (xx)
TW (1) TW472061B (xx)
WO (1) WO1999025365A1 (xx)
YU (1) YU29600A (xx)
ZA (1) ZA9810357B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777282B1 (fr) * 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
WO2000034297A1 (en) * 1998-12-10 2000-06-15 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
ATE256694T1 (de) * 1999-01-27 2004-01-15 Pfizer Prod Inc Ketolid-antibiotika
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
CZ20023290A3 (cs) 2000-04-04 2003-03-12 Smithkline Beecham Plc 2-Hydroxymutilinkarbamátové deriváty pro antibakteriální použití
JP2004323414A (ja) * 2003-04-24 2004-11-18 Japan Science & Technology Agency １４員環マクロライド化合物を利用した、血管平滑筋の増殖に起因する疾患治療剤
GB0402578D0 (en) * 2004-02-05 2004-03-10 Cambridge Theranostics Ltd Methods of treatment of atherosclerosis
JP6042334B2 (ja) * 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424187A (en) * 1991-06-14 1995-06-13 Board Of Regents Of The University Of Washington Method of screening for arterial chlamydial granuloma
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6271255B1 (en) * 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
GB9621771D0 (en) * 1996-10-18 1996-12-11 St George S Enterprises Ltd Method of treatment of heart disease
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics

Also Published As

Publication number Publication date
NO20002435D0 (no) 2000-05-11
AP1196A (en) 2003-08-18
AU1242599A (en) 1999-06-07
TW472061B (en) 2002-01-11
OA11411A (fr) 2004-04-20
NO20002435L (no) 2000-07-07
FR2771008B1 (fr) 2000-04-28
EA003322B1 (ru) 2003-04-24
MA26566A1 (fr) 2004-12-20
TNSN98206A1 (fr) 2005-03-15
DE69825308T2 (de) 2005-08-04
TR200001384T2 (tr) 2001-06-21
ID24940A (id) 2000-08-31
KR20010032130A (ko) 2001-04-16
HUP0004507A1 (hu) 2001-05-28
HUP0004507A3 (en) 2001-12-28
EE04095B1 (et) 2003-08-15
EP1030673A1 (fr) 2000-08-30
DE69825308D1 (de) 2004-09-02
EE200000244A (et) 2001-06-15
US20080139489A1 (en) 2008-06-12
ZA9810357B (en) 1999-11-12
GEP20032968B (en) 2003-05-27
IL136149A0 (en) 2001-05-20
YU29600A (sh) 2003-02-28
HRP20000314A2 (en) 2001-02-28
AU744419B2 (en) 2002-02-21
CN1286633A (zh) 2001-03-07
BR9814199A (pt) 2000-09-26
ES2224446T3 (es) 2005-03-01
NZ504305A (en) 2002-11-26
FR2771008A1 (fr) 1999-05-21
JP4550273B2 (ja) 2010-09-22
JP2001523644A (ja) 2001-11-27
PL340373A1 (en) 2001-01-29
CA2312021C (fr) 2008-08-26
WO1999025365A1 (fr) 1999-05-27
SK7042000A3 (en) 2000-12-11
CA2312021A1 (fr) 1999-05-27
EP1030673B1 (fr) 2004-07-28
EA200000531A1 (ru) 2000-10-30
ATE271875T1 (de) 2004-08-15
AP2000001825A0 (en) 2000-06-30
AR014119A1 (es) 2001-02-07
BG104427A (en) 2001-02-28

Similar Documents

Publication Publication Date Title
CA2206837A1 (fr) Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
MA26536A1 (fr) Association de compositions pharmaceutiques d'atorvastatine et d'agents antihypertensifs, et procede pour leur preparation.
ATE255819T1 (de) Zusammensetzungen von süssigkeiten
DZ2416A1 (fr) Dérivés d'acide arylsulfonylhydroxamique procédé pour leur préparation et compositions les contenant.
PT787745E (pt) Preparacao de produtos de inulina
BR9708793A (pt) Composições ácidas redutoras de cisalhamento espessas
DZ1958A1 (fr) Composés inhibiteurs de l'enzyme l-lpa compositionpharmaceutiques les composant et procédés pour leur préparation.
DZ2752A1 (fr) Composés et compositions pharmaceutiques pour le traitement du paludisme.
DZ2550A1 (fr) Dérivés d'azétidinylpropylpipéridine procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2316A1 (fr) Micro sphères pharmaceutiques d'acide valproique pour administration orale.
CA2340224A1 (en) Nimesulide containing topical pharmaceutical compositions
DZ2654A1 (fr) Utilisations des kétolides pour la préparation de compositions pharmaceutiques destinées à prévenir les complications thrombotiques artérielles liées à l'arthérosclérose.
BR9306531A (pt) Composições de mistura de bebida de psílio
DZ2641A1 (fr) Nouveaux procédés pour la préparation d'oméprazole.
MA23900A1 (fr) Procede pour la preparation de compositions antiretrovirale
CA2337667A1 (en) Dextran-leptin conjugates, pharmaceutical compositions and related methods
FR2686513B1 (fr) Compositions pharmaceutiques aqueuses de cromoglycate sodique.
AU4244996A (en) Buffered emulsion compositions containing actives subject to acid or base hydrolysis
MA25184A1 (fr) Production d'acide pour aliments .
FR2715656B1 (fr) Procédé de préparation d'anhydride citraconique.
FR2699572B1 (fr) Diffuseur de produits sanitaires pour "water-closed".
DZ2770A1 (fr) Procédé de préparation de 1h-indol-3 glyoxamides substituées en position 4.
FR2759587B1 (fr) Composition pharmaceutique pour l'administration buccale de thiocolchicoside
FR2701709B1 (fr) Forme purifiée de streptograminés, sa préparation et les compositions pharmaceutiques qui la contiennent.
BR9809286A (pt) Processos para redução de fibrinogênio